Adenovirus in solid organ transplantation

American Journal of Transplantation

Volumn 13, Issue SUPPL.4, 2013, Pages 206-211

  Florescu, D F ^a   Hoffman, J A ^b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Adenovirus; cidofovir; cystitis; opportunistic infection; viral infection

Indexed keywords

ACICLOVIR; CEPHALOSPORIN; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; COTRIMOXAZOLE; DOUBLE STRANDED DNA; GANCICLOVIR; IMIPENEM; METHOTREXATE; OKT 3; PENICILLIN DERIVATIVE; PROBENECID; RIBAVIRIN; VIRUS DNA;

ADENOVIRUS INFECTION; ANEMIA; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID; DISEASE ASSOCIATION; DNA VIRUS; GENOTYPE; GRAFT INFECTION; GRAFT SURVIVAL; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; INFECTION RISK; INTESTINE GRAFT; INTESTINE LYMPHATIC TISSUE; LATENT VIRUS INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTE COUNT; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE HOMOLOGY; SEROTYPE; SOLID ORGAN TRANSPLANTATION; T LYMPHOCYTE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ADENOVIRIDAE INFECTIONS; HUMANS; INFECTION CONTROL; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 84874825657     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12112     Document Type: Article

References (56)

1. Ruuskanen O, Meurman O, Akusjarvi G,. Adenoviruses. In:, Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. Washington, D.C: ASM Press; 515-535; 2002.
2. Echavarria M,. Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 2008; 21: 704-715.
3. Hoffman JA,. Adenovirus infections in solid organ transplant recipients. Curr Opin Organ Transplant 2009; 14: 625-633.
4. Garnett CT, Erdman D, Xu W, Gooding LR,. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 2002; 76: 10608-10616.
5. Leung AY, Chan M, Cheng VC, Yuen KY, Kwong YL,. Quantification of adenovirus in the lower respiratory tract of patients without clinical adenovirus-related respiratory disease. Clin Infect Dis 2005; 40: 1541-1544.
6. Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003; 76: 183-189.
7. Humar A, Kumar D, Mazzulli T, et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant 2005; 5: 2555-2559.
8. McLaughlin GE, Delis S, Kashimawo L, et al. Adenovirus infection in pediatric liver and intestinal transplant recipients: Utility of DNA detection by PCR. Am J Transplant 2003; 3: 224-228.
9. Ohori NP, Michaels MG, Jaffe R, Williams P, Yousem SA,. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 1995; 26: 1073-1079.
10. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344: 1498-1503.
11. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: A survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003; 31: 481-486.
12. Suparno C, Milligan DW, Moss PA, Mautner V,. Adenovirus infections in stem cell transplant recipients: Recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 2004; 45: 873-885.
13. Michaels MG, Green M, Wald ER, Starzl TE,. Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992; 165: 170-174.
14. McGrath D, Falagas ME, Freeman R, et al. Adenovirus infection in adult orthotopic liver transplant recipients: Incidence and clinical significance. J Infect Dis 1998; 177: 459-462.
15. de Mezerville MH, Tellier R, Richardson S, Hebert D, Doyle J, Allen U,. Adenoviral infections in pediatric transplant recipients: A hospital-based study. Pediatr Infect Dis J 2006; 25: 815-818.
16. Koneru B, Jaffe R, Esquivel CO, et al. Adenoviral infections in pediatric liver transplant recipients. JAMA 1987; 258: 489-492.
17. Engelmann G, Heim A, Greil J, et al. Adenovirus infection and treatment with cidofovir in children after liver transplantation. Pediatr Transplant 2009; 13: 421-428.
18. Bridges ND, Spray TL, Collins MH, Bowles NE, Towbin JA,. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116: 617-623.
19. Doan ML, Mallory GB, Kaplan SL, et al. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant 2007; 26: 883-889.
20. Liu M, Worley S, Arrigain S, et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009; 11: 304-312.
21. Liu M, Mallory GB, Schecter MG, et al. Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010; 14: 431-436.
22. Parizhskaya M, Walpusk J, Mazariegos G, Jaffe R,. Enteric adenovirus infection in pediatric small bowel transplant recipients. Pediatr Dev Pathol 2001; 4: 122-128.
23. Florescu DF, Islam MK, Mercer DF, et al. Adenovirus infections in pediatric small bowel transplant recipients. Transplantation 2010; 90: 198-200.
24. Watcharananan SP, Avery R, Ingsathit A, et al. Adenovirus disease after kidney transplantation: Course of infection and outcome in relation to blood viral load and immune recovery. Am J Transplant 2011; 11: 1308-1314.
25. Humar A, Doucette K, Kumar D, et al. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant 2006; 25: 1441-1446.
26. Ziring D, Tran R, Edelstein S, et al. Infectious enteritis after intestinal transplantation: Incidence, timing, and outcome. Transplantation 2005; 79: 702-709.
27. Berho M, Torroella M, Viciana A, et al. Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant 1998; 2: 277-282.
28. Ison MG,. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43: 331-339.
29. Moulik M, Breinholt JP, Dreyer WJ, et al. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 2010; 56: 582-592.
30. Yagisawa T, Takahashi K, Yamaguchi Y, et al. Adenovirus induced nephropathy in kidney transplant recipients. Transplant Proc 1989; 21 (Pt 2): 2097-2099.
31. Leruez-Ville M, Minard V, Lacaille F, et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis 2004; 38: 45-52.
32. Lankester AC, Heemskerk B, Claas EC, et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 2004; 38: 1521-1525.
33. Seidemann K, Heim A, Pfister ED, et al. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: Report of six cases and review of the literature. Am J Transplant 2004; 4: 2102-2108.
34. Lenaerts L, Naesens L,. Antiviral therapy for adenovirus infections. Antiviral Res 2006; 71: 172-180.
35. Green M, Ljungman P, Michaels M,. Adenovirus, parvovirus B19, papilloma virus, and polyomaviruses after hemopoietic stem cell or solid organ transplantation. In:, Bowden RA, Ljungman P, Paya CV, eds. Transplant infections. Philadelphia: Lippincott Williams & Wilkins; 412-438, 2003.
36. Refaat M, McNamara D, Teuteberg J, et al. Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant 2008; 27: 699-700.
37. Shetty AK, Gans HA, So S, Millan MT, Arvin AM, Gutierrez KM,. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol 2000; 29: 69-73.
38. Duggan JM, Farrehi J, Duderstadt S, Turner NJ, Fekety R,. Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. Am J Med 1997; 103: 439-440.
39. Wreghitt TG, Gray JJ, Ward KN, et al. Disseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovir. J Infect 1989; 19: 88-89.
40. Ljungman P,. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 2004; 23: 583-588.
41. Vistide® (cidofovir injection). Foster City, CA: Gildead Sciences, Inc. 2000. http://www.gilead.com/pdf/vistide.pdf. Accessed October 5, 2012.
42. Hoffman JA, Shah AJ, Ross LA, Kapoor N,. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. BiolBlood Marrow Transplant 2001; 7: 388-394.
43. Anderson EJ, Guzman-Cottrill JA, Kletzel M, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 2008; 12: 219-227.
44. Nagafuji K, Aoki K, Henzan H, et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 909-914.
45. Painter W, Robertson A, Trost LC, Godkin S, Lampert B, Painter G,. First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother 2012; 56: 2726-2734.
46. Toth K, Spencer JF, Dhar D, et al. Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc Natl Acad Sci USA 2008; 105: 7293-7297.
47. Florescu DF, Pergam SA, Neely MN, et al. Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol Blood Marrow Transplant 2012; 18: 731-738.
48. Morfin F, Dupuis-Girod S, Mundweiler S, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 2005; 10: 225-229.
49. Saquib R, Melton LB, Chandrakantan A, et al. Disseminated adenovirus infection in renal transplant recipients: The role of cidofovir and intravenous immunoglobulin. Transpl Infect Dis 2010; 12: 77-83.
50. Emovon OE, Lin A, Howell DN, et al. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: Successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant 2003; 18: 2436-2438.
51. Mawhorter S, Yamani MH,. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 581-585.
52. Chakrabarti S, Collingham KE, Fegan CD, Pillay D, Milligan DW,. Adenovirus infections following haematopoietic cell transplantation: Is there a role for adoptive immunotherapy? Bone Marrow Transplant 2000; 26: 305-307.
53. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134: 64-76.
54. Leen AM, Christin A, Myers GD, et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009; 114: 4283-4292.
55. Salvoldo B, Goss J, Hammer M, et al. Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood 2008; 108: 2942-2949
56. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35 (Suppl 2): S65-164.